Dr Vinay Kumaran has 30 years of expertise as a hepatobiliary and pancreatic surgeon. He specialises in Sleeve Gastrectomy, Kidney Transplant, Pancreas Transplant, Intestinal Transplant, Multi-visceral Transplants, and other procedures. In India, he performed the first dual lobe living donor liver transplant, the first living donor domino liver transplant, the first combined liver and kidney living donor transplant, the first paired donor exchange, the first living donor intestinal transplant, and the first successful living donor cavo-portal transposition in an adult. He is currently associated with Shalby Hospital, Ahmedabad.
He completed his MBBS and MS from Maulana Azad Medical College in New Delhi, as well as his MCh from the All India Institute of Medical Sciences in New Delhi. He then completed a fellowship for multi-organ transplant at Thomas E Starzl Transplantation Institute at the University of Pittsburgh Medical Center. Dr Vinay Kumaran has worked as a Director at Kokilaben Dhirubhai Ambani Hospital in Mumbai and Sir Ganga Ram Hospital in New Delhi in 2013 as well as a Senior Resident at the University College of Medical Sciences in Delhi.
Dr Kumaran finished his training in adult and paediatric liver, pancreas, kidney, intestine, and multi-visceral transplantation. He and his colleagues created some of the most important procedures in living donor liver transplantation, and they've had some of the best results. He worked as a Research Associate at the Albert Einstein College of Medicine's Marion Bessin Liver Research Institute in New York.
He also published several papers, including:
- Wege, H, Le HT, Chui MS, Liu L, Wu J, Giri R, Malhi H, Sappal BS, Kumaran V, Gupta S, Zern MA. Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. Gastroenterology 2003; 124: 432-444
- Kumaran V, Benten D, Follenzi A, Joseph, B, Sarkar R, Gupta S. Transplantation of endothelial cells corrects the phenotype in haemophilia A mice. Journal of Thrombosis and Haemostasis 2005; 3: 2022-2031
- Kumaran V, Joseph, B, Benten D, Gupta S. Integrin and extracellular matrix interactions regulate engraftment of transplanted hepatocytes in the rat liver. Gastroenterology; 129: 1643-1653
- Evolution of a reliable biliary reconstruction technique in 400 consecutive living donor liver transplants. Soin AS, Kumaran V, Rastogi AN, Mohanka R, Mehta N, Saigal S, Saraf N, Mohan N, Nundy S. Journal of the American College of Surgeons 2011: 211: 24-32
- Liver transplantation at Sir Ganga Ram Hospital. Kumaran V. Current Medicine Research and Practice 2011; 1:28-31
- Segment IV preserving middle hepatic vein retrieval in right lobe living donor liver transplantation. Soin AS, Mohanka R, Singla P, Piplani T, Menon B, Kakodkar R, Rastogi A, Goja S, Kumaran V, Nundy S. Journal of the American College of Surgeons 2011, 213 (2): e5-16
- ABO-incompatible liver transplants: room for cautious optimism. Kumaran V. Indian J Gastroenterol. 2014, 33(1):10-1
Some of the treatment provided by Dr Kumaran
- Hepatitis B Treatment
- Hepatitis C Treatment
- Liver Cirrhosis Treatment
- Biliary Drainage and Stenting Surgery
Know about Cirrhosis of the Liver
Cirrhosis of the liver is a disease in which scar tissue replaces healthy liver cells over time. It's a slow-moving illness that takes years to develop. If left unchecked, scar tissue will eventually prohibit the liver from functioning. Cirrhosis requires long-term, ongoing damage to the liver to develop. When good liver tissue is destroyed and replaced by scar tissue, the situation worsens because blood flow through the liver might become obstructed. Alcohol abuse, hepatitis, and fatty liver disease are some of the main causes of cirrhosis.
What is the treatment for liver cirrhosis?
Treatment is determined by the cause of your cirrhosis and the extent of the damage. Cirrhosis has no cure, however, treatments can slow or stop its progression and decrease consequences.
- Medications that may cause cirrhosis include: If any of your drugs are creating difficulties for your liver, your provider will review them all to see if any are causing problems, and if so, they will be stopped, dosed down, or switched to a different drug if feasible.
- Alcohol-related liver disease: If you've acquired cirrhosis as a result of your alcohol addiction, you should stop drinking. If you require assistance, speak with your doctor about alcohol addiction treatment options.
- Nonalcoholic fatty liver disease (NAFLD) is treated by reducing weight, eating a nutritious diet, exercising regularly, and following your doctor's diabetes management guidelines.
- Hepatitis B or C: Hepatitis B and C can be treated with several FDA-approved antiviral medicines.
Dr Vinay Kumaran is a highly skilled and well-known Surgical Gastroenterologist. In his 30 years of expertise in this sector, he has helped thousands of people better their lives. He is currently working with Shalby Hospital in Ahmedabad, which is one of India's leading hospitals.
Send Enquiry